
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Umbilical Cord Blood-Derived Stem Cells,Exosomes,Glutathione
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
Details : Umbilical Cord Blood-Derived Stem Cells is a cell & gene therapy drug candidate, which is currently being evaluated in clinical studies for the treatment of Autism Spectrum Disorder.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Inapplicable
December 26, 2025
Lead Product(s) : Umbilical Cord Blood-Derived Stem Cells,Exosomes,Glutathione
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
